Recombinant Human MIP-4 (CCL18)
MIP-4 is a CC chemokine that is expressed in lymph nodes, lungs, placenta and bone marrow. MIP-4s primary receptor is unknown. MIP-4 chemoattracts lymphocytes, and has been shown to exert activity on both CD4+ and CD8+ T cells. Recombinant human MIP-4 is a 7.8 kDa protein containing 68 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. SLx-2122
|
Source: |
E. Coli
|
|   | |
|
Purity:
|
Above 98% as determined by SDS-PAGE Analysis.
|
|   | |
|
Cross Reactivity: |
NULL
|
|   | |
|
Biological Activity
|
Assay #1: Determined by its ability to chemoattract human T lymphocytes using a concentration of 1.0-10.0 ng/ml.
Assay #2: Determined by its ability to chemoattract human iDCs using a concentration of 1.0-10.0 ng/ml |
|   | |
|
AA Sequence
|
AQVGTNKEL CCLVYTSWQ IPQKFLVDY SETSPQCPK PGVILLTKR GRQICADPN KKWVQKYIS DLKLNA
|
| Research Interest: | |
| Cell Type: | |
| Protein Cross Reactivity: | NULL |